A pilot study discovered that the FSHR Ser680Asn genotype does not influence the follicular fluid hormonal profile or ovulation outcomes in cycles stimulated with varying gonadotropin preparations. The research, involving 40 women undergoing ART, compared two genetic variants and determined no significant impact on treatment results.
Read More
NDLEA Thwarts Major Drug Trafficking Scheme, Seizing Cocaine and Opioids Bound for USA, UK, Europe
Dangote Refinery Cuts Petrol Prices to Boost Holiday Cheer in Nigeria
Roma's Summer Shake-Up: Houssem Aouar Among Potential Departures Amidst Major Squad Overhaul
Liverpool FC's First Black Player Howard Gayle Honored With Commemorative Mural
Senate Schedules Special Session for Meru Governor Kawira Mwangaza's Impeachment
